Dr. Krag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Main Paviliionlevel 2
Burlington, VT 05401Phone+1 802-656-5830Fax+1 802-656-5833
Education & Training
- University of California Davis HealthResidency, Surgery, 1982 - 1986
- Yale-New Haven Medical CenterResidency, Surgery, 1980 - 1982
- Loyola University Chicago Stritch School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1982 - Present
- VT State Medical License 1991 - 2024
- FL State Medical License 2017 - 2019
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsSentinel node mapping in anal canal cancer: systematic review and meta-analysis.Shahrzad Tehranian, Giorgio Treglia, David N. Krag, V.R. Dabbagh Kakhki, Seyed Rasoul Zakavi
Journal of Gastrointestinal and Liver Diseases. 2013-09-01 - 334 citationsMorbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissectionTakamaru Ashikaga, David N. Krag, Stephanie R. Land, Thomas B. Julian, Stewart J. Anderson
Journal of Surgical Oncology. 2010-08-01 - 1 citationsPreparation of clinical-grade WBCs using leukocyte reduction filters.Girja S. Shukla, Stephanie C. Pero, Linda Mei, Shelly Hitchcox, Mark K. Fung
Journal of Immunological Methods. 2021-09-28
Press Mentions
- Tuesday CoronaBuzz, May 5, 2020: 30 Pointers to New Resources, Useful Stuff, Research News, and MoreMay 4th, 2020
Grant Support
- Sentinel Node Versus Axillary Dissection In Breast CancerNational Cancer Institute2007–2011
- Detection Of Micrometastatic Cancer Cells In Blood &Bone Marrow - Breast CancerNational Center For Research Resources2007
- Detection Of RARE Disseminated Tumor Cells In Blood And Bone MarrowNational Center For Research Resources2006–2007
- Serial Evaluation Of Serum Protein Profile Following Breast Cancer TreatmentNational Center For Research Resources2005–2007
- Targeted Enzymes For Prodrug TherapyNational Cancer Institute2005–2007
- In Vivo Selection Of Ligands For Targeted TherapyNational Center For Research Resources2004–2007
- Sentinel Node Versus Axillary Dissection In Breast CA.National Cancer Institute2005–2006
- Detection Of Micrometastatic Cancer Cells In Blood/Bone Marrow -Breast CancerNational Center For Research Resources2004–2006
- Detection Of Cancer Cells Added To Blood Samples Taken From Healthy IndividualsNational Center For Research Resources2004–2006
- Adjuvant Alfa-2b For Melanoma Patients With Early Lymph Node MetastasisNational Center For Research Resources2004–2006
- Targeting Breast Cancer With Small LigandsNational Cancer Institute1999–2006
- In Vivo Selection Of Ligands For Targeted TherapyNational Cancer Institute2002–2003
- Sentinel Node Versus Axillary Dissection--Breast CancerNational Cancer Institute2001–2003
- Adjuvant Interferon Alfa 2B For Melanoma PTS W/ Early Lymph Node MetastasesNational Center For Research Resources1999–2002
- Identification Of Small Peptides Which Target Cancer CELNational Cancer Institute2000–2001
- Sentinel Node In Breast Conserving TherapyNational Cancer Institute1998–2000
- Minimal Access Surgery For Staging Breast CancerNational Cancer Institute1994–1997
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: